Breaking News

SK pharmteco Opens New CGMP Plasmid Suite in King of Prussia

Enhances SK pharmteco’s position as a key partner in advancing the CGT landscape.

Author Image

By: Charlie Sternberg

Associate Editor

SK pharmteco, a global contract development and manufacturing organization (CDMO), has opened its new Current Good Manufacturing Practice (CGMP) plasmid suite at its facility in King of Prussia, Pennsylvania. This strategic expansion underscores SK pharmteco’s commitment to providing a reliable and scalable supply of high-quality plasmids, a critical component in developing life-changing cell and gene therapies (CGTs). Located strategically in the heart of a central hub for potential customer...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters